CC
MGNX icon

Corton Capital’s MacroGenics MGNX Stock Holding History

Corton Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,876
Closed -$78.6K – 628
2023
Q3 		$78.6K Sell
16,876
-56,802
-77% -$283K 0.04% 399
2023
Q2 		$394K Sell
73,678
-1,648
-2% -$10.2K 0.19% 150
2023
Q1 		$540K Buy
+75,326
New +$454K 0.37% 50

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Corton Capital's MGNX Position: Q4 2023 in Review

Corton Capital sold out of MacroGenics (MGNX) in Q4 2023, closing a stake of 16,876 shares — an estimated $78.6K sold.

Corton Capital first reported a position in MGNX in Q1 2023 and held it in 3 quarters. The position peaked at $540K in Q1 2023. 142 funds tracked by Wall St. Rank hold MGNX as of Q4 2023.

  • Corton Capital reported no remaining MacroGenics position as of Q4 2023 after selling out during the quarter.
  • Corton Capital sold 16,876 MacroGenics shares in Q4 2023, an estimated $78.6K.
  • Corton Capital first reported a position in MacroGenics in Q1 2023 and held it in 3 quarters.
  • Corton Capital's MacroGenics position peaked at $540K in Q1 2023.
  • 142 funds tracked by Wall St. Rank held MacroGenics as of Q4 2023.

Based on Corton Capital's 13F filing for Q4 2023, filed 14 Feb 2024.